» » »

Alternative to Warfarin for Arrhythmia Durham NC

Closing the heart's left atrial appendage could offer an alternative to long-term warfarin treatment for people with non-valvular atrial fibrillation who are at risk for stroke, according to a new study. Atrial fibrillation, the most common type of irregular heartbeat, causes the upper chambers of the heart to quiver. This can cause blood to pool and form clots in the left atrial appendage (LAA), a long, tubular structure connected to the left atrial cavity.

Sidney C Smith Jr., MD
(919) 966-5201
130 Mason Farm Rd
Chapel Hill, NC
Business
UNC Cardiology
Specialties
Cardiology

Data Provided by:
Robert Anderson
(919) 620-4467
2100 Erwin Rd
Durham, NC
Specialty
Thoracic Surgery, Vascular Surgery, Cardiac Surgery

Data Provided by:
Alan Harold Friedman, MD
(919) 681-6421
Durham, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Wayne State Univ Sch Of Med, Detroit Mi 48201
Graduation Year: 1987

Data Provided by:
Joseph Gordon Rogers, MD
(919) 681-3398
Box 3034,
Durham, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Univ Of Ne Coll Of Med, Omaha Ne 68198
Graduation Year: 1988

Data Provided by:
Igor Klem
(919) 684-8111
2100 Erwin Rd
Durham, NC
Specialty
Cardiovascular Disease

Data Provided by:
Adrian Felipe Hernandez, MD
(919) 668-7515
1107 Minerva Ave
Durham, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Univ Of Tx Southwestern Med Ctr At Dallas, Med Sch, Dallas Tx 75235
Graduation Year: 1997

Data Provided by:
Piers Barker
(919) 620-4467
2100 Erwin Rd
Durham, NC
Specialty
Cardiology, Pediatric Cardiology

Data Provided by:
Victor Behar
(919) 620-4467
2100 Erwin Rd
Durham, NC
Specialty
Cardiology, Cardiovascular Disease

Data Provided by:
Joseph Kisslo
(919) 620-4467
2100 Erwin Rd
Durham, NC
Specialty
Cardiology, Cardiovascular Disease

Data Provided by:
Pamela Susan Douglas, MD
(919) 681-2690
Erwin Road ? Duke North 7451 Mailstop 3943 Erwin Rd,
Durham, NC
Specialties
Cardiology
Gender
Female
Education
Medical School: Va Commonwealth Univ, Med Coll Of Va Sch Of Med, Richmond Va 23298
Graduation Year: 1978

Data Provided by:
Data Provided by:

Alternative to Warfarin for Arrhythmia

Provided By:

Closing the heart's left atrial appendage could offer an alternative to long-term warfarin treatment for people with non-valvular atrial fibrillation who are at risk for stroke, according to a new study.

Atrial fibrillation, the most common type of irregular heartbeat, causes the upper chambers of the heart to quiver. This can cause blood to pool and form clots in the left atrial appendage (LAA), a long, tubular structure connected to the left atrial cavity. More than 90 percent of atrial blood clots in people with non-valvular atrial fibrillation may originate in the LAA, according to background information in the study.

The study included 463 people who underwent percutaneous implantation of a device, known as the Watchman, to close off the LAA. Their outcomes were compared with those of 244 people who continued long-term treatment with warfarin.

The researchers determined the effectiveness of the treatments by assessing the occurrence, during an average follow-up of 18 months, of strokes, death from cardiovascular causes and systemic embolisms (blood clots that go somewhere other than the brain). They also totaled the occurrence of such serious problems as major bleeding, pericardial effusion (accidental puncture of the heart causing fluid collection in the heart sac) and clots caused by the implanted device.

After 1,065 patient-years of follow-up, there were 3.0 such occurrences per 100 patient-years among those who'd had the device implanted, compared with 4.9 in the warfarin group, for a risk reduction of 38 percent. But people in the device group had more serious safety events -- 7.4 events per 100 patient-years versus 4.4 events in the warfarin group, the researchers found.

"The efficacy of percutaneous closure of the LAA with this device was non-inferior to that of warfarin therapy," concluded Dr. David R. Holmes, of the Mayo Clinic in Rochester, Minn., and his colleagues. "Although there was a higher rate of adverse safety events in the intervention group than the control group, events in the intervention group were mainly a result of periprocedural complications," they wrote.

"Closure of the LAA might provide an alternative strategy to chronic warfarin therapy for stroke prophylaxis in patients with non-valvular atrial fibrillation," they added.

The study appears this week in The Lancet.

More information

The American Academy of Family Physicians has more about atrial fibrillation.

SOURCE: The Lancet, news release, Aug. 13, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com